To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug ...

Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...

The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with ...

The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with projections indicating strong uptake in biosimilars at the expense of the ...

Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...

The 2024 surge in FDA approvals for aflibercept biosimilars reflects significant progress in offering cost-effective ...

The top 5 rheumatology biosimilar articles of 2024 focus on key developments in biosimilar approvals and treatment options. These include the FDA's approval of innovative formulations, such as a ...

On this episode of Not So Different, we reflect on 2024 and this show in particular, taking audiences back through the most popular podcast episodes of the year. The top 5 podcast episodes of the year ...

Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...

The top biosimilar policy articles of 2024 highlight advancements that include FDA guidance to simplify biosimilar ...